XRAY Quote, Financials, Valuation and Earnings

Biolase has a net margin of -47.51% compared to Dentsply Sirona's net margin of -13.16%. Dentsply Sirona's return on equity of -32.39% beat Biolase's return on equity of -21668.17%.

Dentsply Sirona has a consensus price target of $20.00, signalling upside risk potential of 47.28%. On the other hand Biolase has an analysts' consensus of $1.2000 which suggests that it could grow by 18418.52%. Given that Biolase has higher upside potential than Dentsply Sirona, analysts believe Biolase is more attractive than Dentsply Sirona.

Dentsply Sirona has a beta of 0.918, which suggesting that the stock is 8.232% less volatile than S&P 500. In comparison Biolase has a beta of 0.211, suggesting its less volatile than the S&P 500 by 78.874%.

Dentsply Sirona has a quarterly dividend of $0.16 per share corresponding to a yield of 4.71%. Biolase offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Dentsply Sirona pays -13.85% of its earnings as a dividend. Biolase pays out -- of its earnings as a dividend.

Dentsply Sirona quarterly revenues are $905M, which are larger than Biolase quarterly revenues of $10.9M. Dentsply Sirona's net income of -$430M is lower than Biolase's net income of -$1.4M. Notably, Dentsply Sirona's price-to-earnings ratio is -- while Biolase's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Dentsply Sirona is 0.73x versus 0.01x for Biolase. Usually stocks with elevated PS ratios are considered overvalued.

Milestone Scientific has a net margin of -47.51% compared to Dentsply Sirona's net margin of -58.13%. Dentsply Sirona's return on equity of -32.39% beat Milestone Scientific's return on equity of -61.33%.

Dentsply Sirona has a consensus price target of $20.00, signalling upside risk potential of 47.28%. On the other hand Milestone Scientific has an analysts' consensus of -- which suggests that it could grow by 144.28%. Given that Milestone Scientific has higher upside potential than Dentsply Sirona, analysts believe Milestone Scientific is more attractive than Dentsply Sirona.

Dentsply Sirona has a beta of 0.918, which suggesting that the stock is 8.232% less volatile than S&P 500. In comparison Milestone Scientific has a beta of 1.124, suggesting its more volatile than the S&P 500 by 12.429%.

Dentsply Sirona has a quarterly dividend of $0.16 per share corresponding to a yield of 4.71%. Milestone Scientific offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Dentsply Sirona pays -13.85% of its earnings as a dividend. Milestone Scientific pays out -- of its earnings as a dividend.

Dentsply Sirona quarterly revenues are $905M, which are larger than Milestone Scientific quarterly revenues of $2.5M. Dentsply Sirona's net income of -$430M is lower than Milestone Scientific's net income of -$1.5M. Notably, Dentsply Sirona's price-to-earnings ratio is -- while Milestone Scientific's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Dentsply Sirona is 0.73x versus 7.68x for Milestone Scientific. Usually stocks with elevated PS ratios are considered overvalued.

Envista Holdings has a net margin of -47.51% compared to Dentsply Sirona's net margin of 0.18%. Dentsply Sirona's return on equity of -32.39% beat Envista Holdings's return on equity of -32.33%.

Dentsply Sirona has a consensus price target of $20.00, signalling upside risk potential of 47.28%. On the other hand Envista Holdings has an analysts' consensus of $21.33 which suggests that it could grow by 37.81%. Given that Dentsply Sirona has higher upside potential than Envista Holdings, analysts believe Dentsply Sirona is more attractive than Envista Holdings.

Dentsply Sirona has a beta of 0.918, which suggesting that the stock is 8.232% less volatile than S&P 500. In comparison Envista Holdings has a beta of 1.120, suggesting its more volatile than the S&P 500 by 12.044%.

Dentsply Sirona has a quarterly dividend of $0.16 per share corresponding to a yield of 4.71%. Envista Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Dentsply Sirona pays -13.85% of its earnings as a dividend. Envista Holdings pays out -- of its earnings as a dividend.

Dentsply Sirona quarterly revenues are $905M, which are larger than Envista Holdings quarterly revenues of $652.9M. Dentsply Sirona's net income of -$430M is lower than Envista Holdings's net income of $1.2M. Notably, Dentsply Sirona's price-to-earnings ratio is -- while Envista Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Dentsply Sirona is 0.73x versus 1.07x for Envista Holdings. Usually stocks with elevated PS ratios are considered overvalued.

Solventum has a net margin of -47.51% compared to Dentsply Sirona's net margin of 1.49%. Dentsply Sirona's return on equity of -32.39% beat Solventum's return on equity of 9.76%.

Dentsply Sirona has a consensus price target of $20.00, signalling upside risk potential of 47.28%. On the other hand Solventum has an analysts' consensus of $80.89 which suggests that it could grow by 22.19%. Given that Dentsply Sirona has higher upside potential than Solventum, analysts believe Dentsply Sirona is more attractive than Solventum.

Dentsply Sirona has a beta of 0.918, which suggesting that the stock is 8.232% less volatile than S&P 500. In comparison Solventum has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Dentsply Sirona has a quarterly dividend of $0.16 per share corresponding to a yield of 4.71%. Solventum offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Dentsply Sirona pays -13.85% of its earnings as a dividend. Solventum pays out -- of its earnings as a dividend.

Dentsply Sirona quarterly revenues are $905M, which are smaller than Solventum quarterly revenues of $2.1B. Dentsply Sirona's net income of -$430M is lower than Solventum's net income of $31M. Notably, Dentsply Sirona's price-to-earnings ratio is -- while Solventum's PE ratio is 24.07x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Dentsply Sirona is 0.73x versus 1.39x for Solventum. Usually stocks with elevated PS ratios are considered overvalued.